Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Invested Capital (2016 - 2025)

Historic Invested Capital for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $26.1 million.

  • Cumberland Pharmaceuticals' Invested Capital fell 1510.71% to $26.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.1 million, marking a year-over-year decrease of 1510.71%. This contributed to the annual value of $28.0 million for FY2024, which is 557.35% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Invested Capital is $26.1 million, which was down 1510.71% from $28.0 million recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Invested Capital high stood at $48.0 million for Q2 2021, and its period low was $26.1 million during Q3 2025.
  • Moreover, its 5-year median value for Invested Capital was $36.3 million (2022), whereas its average is $35.5 million.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 2909.12% in 2024, then surged by 622.72% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Invested Capital (Quarter) stood at $42.8 million in 2021, then dropped by 15.29% to $36.3 million in 2022, then decreased by 18.37% to $29.6 million in 2023, then dropped by 5.57% to $28.0 million in 2024, then fell by 6.56% to $26.1 million in 2025.
  • Its Invested Capital stands at $26.1 million for Q3 2025, versus $28.0 million for Q2 2025 and $28.7 million for Q1 2025.